查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1396938

冠狀動脈繞道手術旁路移植裝置市場：按技術、按產品、最終用戶分類：2023-2032 年全球機會分析和產業預測

Coronary Artery Bypass Grafts Device Market By Technology, By Product, By End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 259 Pages | 商品交期: 2-3個工作天內

價格

2022年冠狀動脈繞道手術繞道移植裝置市值為9.5927億美元，預計2032年將達到13.823億美元，2023年至2032年年複合成長率為3.7%。

2022年，全球冠狀動脈繞道手術旁路移植設備市場價值為 9.6 億美元，預計2023年至2032年年複合成長率為 3.7%，到2032年達到 13.8 億美元。

冠狀動脈繞道手術手術（CABG）裝置在冠狀動脈疾病的外科治療中發揮重要作用。冠狀動脈疾病是一種向心肌供血的血管因斑塊堆積而變窄或阻塞的疾病。冠狀動脈繞道手術手術是一種外科手術，透過用健康的血管繞過阻塞或狹窄的冠狀動脈來恢復心肌的充足血流。一般來說，體外循環和非體外循環是冠狀動脈繞道手術的兩種類型，不同之處在於體外迴圈輔助下冠狀動脈繞道手術手術使用心肺體外迴圈迴路和停止的心臟來執行手術。另一方面，在非體外迴圈冠狀動脈繞道手術繞道手術中，外科醫生在脈動熱量下進行手術。

推動冠狀動脈繞道手術手術移植裝置市場成長的主要因素是老年人口的增加，因為他們有開拓心臟疾病（CHD）和動脈硬化等相關疾病的風險；隨著年齡的成長，老年人口顯著增加。此外，由於生活方式改變、久坐習慣、不健康飲食和壓力水準上升而導致心臟疾病率迅速上升，預計也將推動市場成長。隨著年齡的成長，冠狀動脈疾病（CAD）和相關心臟病的風險顯著增加。冠狀動脈疾病是一種全球流行的疾病，其特徵是冠狀動脈中斑塊積聚和流向心肌的血流減少。例如，美國心臟協會2023年報告估計，男性首次心臟病發作的平均年齡為 65.6 歲，女性為 72.0 歲。

冠狀動脈繞道手術繞道手術是用於治療嚴重冠狀動脈疾病的重要外科手術。冠狀動脈繞道手術手術包括從身體其他部位移植健康的血管來繞過阻塞或狹窄的冠狀動脈，創建替代的血液途徑並恢復流向心臟的正常血液。隨著人口老化變得更容易患冠狀動脈疾病和相關心血管疾病，對冠狀動脈繞道手術繞道手術和相關設備的需求迅速增加。此外，老年人通常患有多種合併症，與更具侵入性和複雜的手術相比，使他們成為冠狀動脈繞道手術繞道手術的理想候選者。總之，冠狀動脈疾病高盛行率的老年人口不斷增加是冠狀動脈繞道手術手術市場成長的關鍵驅動力。

目錄

第1章 簡介

第2章 執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 心血管疾病迅速增加。
      • 不健康的飲食習慣和現代久坐的生活方式。
      • 老年人口增加。
    • 抑制因素
      • 冠狀動脈繞道手術旁路移植裝置的高成本。
    • 機會
      • 提高心臟健康意識。

第4章 冠狀動脈繞道手術旁路移植裝置市場：依技術分類

  • 概述
  • 非體外循環冠狀動脈繞道術
  • 體外循環冠狀動脈繞道手術
  • 微創冠狀動脈繞道手術

第5章 冠狀動脈繞道手術旁路移植裝置市場：依產品

  • 概述
  • 心肺機
  • 內視鏡血管採集系統
  • 心臟定位器
  • 組織穩定劑
  • 其他

第6章 冠狀動脈繞道手術旁路移植裝置市場：依最終用戶分類

  • 概述
  • 醫院
  • 心臟中心
  • 其他

第7章 冠狀動脈繞道手術旁路移植裝置市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • LAMEA
    • 拉丁美洲
    • 中東、非洲

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Medtronic
  • Baxter International Inc.
  • Terumo Corporation
  • Peters Surgical Group
  • Getinge AB
  • Genesee Biomedical Inc
  • Transonic Systems Inc.
  • Livanova, Plc
  • Condor MedTec GmbH
  • Saphena Medical, Inc.
Product Code: A197949

The coronary artery bypass grafts device market was valued at $959.27 million in 2022 and is estimated to reach $1,382.30 million by 2032, exhibiting a CAGR of 3.7% from 2023 to 2032. The global coronary artery bypass grafts device market was valued at $0.96 billion in 2022, and is projected to reach $1.38 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Coronary artery bypass graft (CABG) device plays an important role in the surgical treatment of coronary artery disease. Coronary artery disease is a condition where the blood vessels supplying blood to the heart muscles become narrowed or blocked due to the buildup of plaque. Coronary artery bypass graft is a surgical procedure which is carried out to restore adequate blood flow to the heart muscles by bypassing the blocked or narrowed coronary arteries with healthy blood vessels. In general, on-pump and off-pump are the two types of CABG surgical procedures with the difference being the use of a cardiopulmonary bypass circuit and an arrested heart to operate during an on-pump coronary artery bypass graft. On the other hand, during off-pump coronary artery bypass graft, the surgeons operates on the beating heat.

The key factors driving the growth of the coronary artery bypass graft devices market are rise in geriatric population as they have the risk of developing coronary heart disease (CHD) and related conditions such as atherosclerosis increases significantly with age. Furthermore, surge in prevalence of coronary heart diseases owing to lifestyle changes, sedentary habits, unhealthy diets, and increase in stress levels is also expected to drive the growth of the market. As people age, their risk of developing coronary artery disease (CAD) and related cardiac issues significantly increases. Coronary artery disease is a prevalent condition worldwide, characterized by the accumulation of plaque in the coronary arteries, leading to reduced blood flow to the heart muscle. For instance, according to a 2023 report by American Heart Association, it was estimated that the average age at the first heart attack was 65.6 years for males and 72.0 years for females.

Coronary artery bypass grafting is a crucial surgical intervention used to treat severe coronary artery disease. It involves the creation of alternative blood pathways by grafting healthy blood vessels from other parts of the body to bypass the blocked or narrowed coronary arteries, thereby restoring proper blood flow to the heart. As the geriatric population is more prone to coronary artery disease and related cardiovascular problems, the demand for coronary artery bypass graft procedures and associated devices has surged. Furthermore, the elderly often have multiple comorbidities, making them ideal candidates for coronary artery bypass graft surgeries as compared to more invasive or complex procedures. In conclusion, the escalating geriatric population, with its higher susceptibility to coronary artery disease, has become a pivotal driver for the growth of the coronary artery bypass graft devices market.

In addition, surge in prevalence of coronary heart disease is expected to act as a significant driver for the coronary artery bypass graft devices market. The bypass restores the blood flow to the ischemic myocardium which, in turn, restores function, viability, and relieves anginal symptoms. The global burden of coronary heart disease has been on the rise, primarily attributed to lifestyle factors such as sedentary lifestyles, unhealthy diets, and increasing rates of obesity. For instance, according to a 2023 report by U.S. National library of medicine, it was estimated that globally almost 400,000 coronary artery bypass grafting surgeries are performed each year making it the most commonly performed major surgical procedure. Thus, the surge in the prevalence of coronary heart disease is expected to drive the growth of the coronary artery bypass graft devices market.

However, high cost of procedures might act as restraint for the coronary artery bypass graft devices market. The high cost of coronary artery bypass graft surgery makes it less accessible to individuals without adequate health insurance coverage. The cost of devices, hospital stays, and post-operative care be a significant financial burden for patients.

The coronary artery bypass graft devices market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into off-pump, on-pump, and minimally invasive CABG. By product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer and others. By end user, the market is divided into hospitals, cardiac centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global coronary artery bypass graft devices market are Medtronic, Baxter International Inc, Terumo Corporation, Teleflex Incorporated, Peters Surgical Group, Getinge AB, Genesee Biomedical Inc, Transonic Systems Inc., Saphena Medical, Inc. and Condor MedTec GmbH.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary artery bypass grafts device market analysis from 2022 to 2032 to identify the prevailing coronary artery bypass grafts device market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the coronary artery bypass grafts device market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global coronary artery bypass grafts device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Technology Trend Analysis
  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By End Users

  • Hospitals
  • Cardiac Centers
  • Others

By Technology

  • Off pump CABG
  • On pump CABG
  • Minimally invasive CABG

By Product

  • Endoscopic Vessel Harvesting Systems
  • Heart Positioners
  • Tissue Stabilizer
  • Others
  • Cardiopulmonary Bypass Machines

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East And Africa

Key Market Players:

    • Terumo Corporation
    • Peters Surgical Group
    • Genesee Biomedical Inc
    • Transonic Systems Inc.
    • Condor MedTec GmbH
    • Baxter International Inc.
    • Getinge AB
    • Saphena Medical, Inc.
    • Medtronic
    • Livanova, Plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Surge in prevalence of cardiovascular diseases.
      • 3.4.1.2. Unhealthy diet and modern sedentary lifestyle.
      • 3.4.1.3. Rise in geriatric population.
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of coronary artery bypass graft devices.
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in awareness about heart health

CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Off pump CABG
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. On pump CABG
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Minimally invasive CABG
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cardiopulmonary Bypass Machines
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Endoscopic Vessel Harvesting Systems
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Heart Positioners
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Tissue Stabilizer
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cardiac Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Technology
    • 7.2.3. Market size and forecast, by Product
    • 7.2.4. Market size and forecast, by End Users
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Technology
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by End Users
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Technology
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by End Users
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Technology
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by End Users
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Technology
    • 7.3.3. Market size and forecast, by Product
    • 7.3.4. Market size and forecast, by End Users
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Technology
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by End Users
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Technology
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by End Users
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Technology
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by End Users
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Technology
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by End Users
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Technology
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by End Users
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Technology
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by End Users
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Technology
    • 7.4.3. Market size and forecast, by Product
    • 7.4.4. Market size and forecast, by End Users
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Technology
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by End Users
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Technology
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by End Users
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Technology
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by End Users
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Technology
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by End Users
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Technology
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by End Users
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Technology
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by End Users
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Technology
    • 7.5.3. Market size and forecast, by Product
    • 7.5.4. Market size and forecast, by End Users
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Latin America
      • 7.5.5.1.1. Market size and forecast, by Technology
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by End Users
      • 7.5.5.2. Middle East And Africa
      • 7.5.5.2.1. Market size and forecast, by Technology
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by End Users

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Baxter International Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Terumo Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Peters Surgical Group
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Getinge AB
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Genesee Biomedical Inc
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Transonic Systems Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Livanova, Plc
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Condor MedTec GmbH
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Saphena Medical, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 02. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 06. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 12. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 20. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 23. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 24. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 39. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 40. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 42. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 43. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 58. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 59. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 62. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 77. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 80. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 81. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 83. MEDTRONIC: KEY EXECUTIVES
  • TABLE 84. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 85. MEDTRONIC: PRODUCT SEGMENTS
  • TABLE 86. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 87. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 88. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 89. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 90. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 91. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 92. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. TERUMO CORPORATION: PRODUCT SEGMENTS
  • TABLE 94. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 95. PETERS SURGICAL GROUP: KEY EXECUTIVES
  • TABLE 96. PETERS SURGICAL GROUP: COMPANY SNAPSHOT
  • TABLE 97. PETERS SURGICAL GROUP: PRODUCT SEGMENTS
  • TABLE 98. PETERS SURGICAL GROUP: PRODUCT PORTFOLIO
  • TABLE 99. GETINGE AB: KEY EXECUTIVES
  • TABLE 100. GETINGE AB: COMPANY SNAPSHOT
  • TABLE 101. GETINGE AB: PRODUCT SEGMENTS
  • TABLE 102. GETINGE AB: PRODUCT PORTFOLIO
  • TABLE 103. GENESEE BIOMEDICAL INC: KEY EXECUTIVES
  • TABLE 104. GENESEE BIOMEDICAL INC: COMPANY SNAPSHOT
  • TABLE 105. GENESEE BIOMEDICAL INC: PRODUCT SEGMENTS
  • TABLE 106. GENESEE BIOMEDICAL INC: PRODUCT PORTFOLIO
  • TABLE 107. TRANSONIC SYSTEMS INC.: KEY EXECUTIVES
  • TABLE 108. TRANSONIC SYSTEMS INC.: COMPANY SNAPSHOT
  • TABLE 109. TRANSONIC SYSTEMS INC.: PRODUCT SEGMENTS
  • TABLE 110. TRANSONIC SYSTEMS INC.: PRODUCT PORTFOLIO
  • TABLE 111. LIVANOVA, PLC: KEY EXECUTIVES
  • TABLE 112. LIVANOVA, PLC: COMPANY SNAPSHOT
  • TABLE 113. LIVANOVA, PLC: PRODUCT SEGMENTS
  • TABLE 114. LIVANOVA, PLC: PRODUCT PORTFOLIO
  • TABLE 115. LIVANOVA, PLC: KEY STRATERGIES
  • TABLE 116. CONDOR MEDTEC GMBH: KEY EXECUTIVES
  • TABLE 117. CONDOR MEDTEC GMBH: COMPANY SNAPSHOT
  • TABLE 118. CONDOR MEDTEC GMBH: PRODUCT SEGMENTS
  • TABLE 119. CONDOR MEDTEC GMBH: PRODUCT PORTFOLIO
  • TABLE 120. SAPHENA MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 121. SAPHENA MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 122. SAPHENA MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 123. SAPHENA MEDICAL, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2020 TO 2022)
  • FIGURE 04. TOP INVESTMENT POCKETS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2022-2023)
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2023)
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2022-2023)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. MEDTRONIC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 51. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. MEDTRONIC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)
  • FIGURE 57. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 58. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 59. GETINGE AB: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. GETINGE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. GETINGE AB: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. LIVANOVA, PLC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 63. LIVANOVA, PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 64. LIVANOVA, PLC: REVENUE SHARE BY REGION, 2022 (%)